ELCC Real-world increase in biomarker testing in lung cancer patients, registry study reveals April 5, 2022 More than half of patients diagnosed with advanced non-small cell lung cancer (NSCLC) undergo biomarker…
ELCC Specific lung cancer screening and treatment policies urgently needed April 5, 2022 A consensus reached by a lung clinical community within the International Cancer Benchmarking Partnership (ICBP),…